Educational guide
New drug combo lowers LDL cholesterol by 48.6%
932,088 followers 1y Lowering your LDL cholesterol can be crucial for managing heart disease. A new drug combination lowered it by nearly half in a new clinical trial. The new findings by Cleveland Clinic physicians show that the combination of obicetrapib and
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
932,088 followers
1y
Lowering your LDL cholesterol can be crucial for managing heart disease. A new drug combination lowered it by nearly half in a new clinical trial. The new findings by Cleveland Clinic physicians show that the combination of obicetrapib and ezetimibe reduced LDL cholesterol levels by 48.6% after about three months. It produced more effective results than either drug alone. The findings were presented at the European Atherosclerosis Society’s annual meeting and simultaneously published in The Lancet. Too much LDL cholesterol (often referred to as the “bad” cholesterol) can lead to atherosclerotic disease - plaque buildup in the walls of arteries - that can increase the risk for a heart attack or stroke. Many factors can result in high levels of LDL, such as poor diet, being overweight, smoking and increased age. Other factors, such as genetics, cannot be modified. For some people, lifestyle modifications are beneficial, but for many others, medications are required.